Dr. Hezel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Avenue
Box 704
Rochester, NY 14642Phone+1 585-275-5853Fax+1 585-273-1051
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2003 - 2006
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2000 - 2003
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2000
Certifications & Licensure
NY State Medical License 2009 - 2026
MA State Medical License 2002 - 2010- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer Start of enrollment: 2009 May 01
- Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer Start of enrollment: 2010 Dec 01
- PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer Start of enrollment: 2013 May 14
Publications & Presentations
PubMed
- 140 citationsAssociation of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal AdenocarcinomaZhi Rong Qian, Douglas A. Rubinson, Jonathan A. Nowak, Vicente Morales-Oyarvide, Richard F. Dunne
JAMA Oncology. 2017-11-02 - 24 citationsNeoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer.Andressa Dias Costa, Sara A Väyrynen, Akhil Chawla, Jinming Zhang, Juha P Väyrynen
Clinical Cancer Research. 2022-12-01 - 1039 citationsOncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolismHaoqiang Ying, Alec C. Kimmelman, Costas A. Lyssiotis, Sujun Hua, Gerald C. Chu
Cell. 2012-04-27
Journal Articles
- Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic CancerRichard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature
Press Mentions
Gene Mutations Drive Bile Duct CancerAugust 31st, 2022- Life-Threatening CostsNovember 11th, 2021
Study Points to Obesity as Driver of Pancreatic CancerApril 16th, 2020- Join now to see all
Grant Support
- Genomic Instability And The Roles Of P53 And P19ARF In Pancreatic CancerNational Cancer Institute2009–2010
- Genomic Instability And The Roles Of P53 And P19ARF In Pancreatic CancerNational Cancer Institute2006–2008
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
